Position in NVO
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$32,112,992
New position
Shares Held
669,858
first reported quarter
Ownership
0.015%
of shares outstanding
% of Portfolio
1.39%
of 13F equity value
Holder Rank
#70
of 1,348 holders
Holding Since
Jun 2026
1 quarter on record
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SNS Financial Group, LLC holds $152,677,395 across 10 Drug Manufacturers - General names. NVO ranks #3 (21.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
46,863 | $56,208,892 | |
| 2 | JNJ |
Johnson & Johnson
|
172,754 | $43,874,333 | |
| 3 | NVO |
Novo Nordisk A S
This page
|
669,858 | $32,112,992 | |
| 4 | ABBV |
AbbVie Inc.
|
32,457 | $8,167,479 | |
| 5 | PFE |
Pfizer Inc
|
167,096 | $4,023,671 | |
| 6 | MRK |
Merck & Co., Inc.
|
27,952 | $3,591,832 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
36,127 | $2,081,637 | |
| 8 | AMGN |
Amgen Inc
|
2,842 | $1,029,145 |
All Filings in NVO
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $32,112,992 | 669,858 | Shares | Sole | 2026-08-11 | |
| No filing history on record for this holder in this stock. | ||||||